HomeHBP • TSE
add
Helix Biopharma Corp
Previous close
$0.97
Day range
$0.96 - $0.96
Year range
$0.50 - $1.35
Market cap
50.90M CAD
Avg Volume
3.26K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.29M | 43.24% |
Net income | -1.38M | -52.44% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.29M | -43.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.00M | 1,563.33% |
Total assets | 2.24M | 551.74% |
Total liabilities | 2.26M | 274.96% |
Total equity | -19.00K | — |
Shares outstanding | 53.02M | — |
Price to book | ∞ | — |
Return on assets | -243.22% | — |
Return on capital | 467.10% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -1.38M | -52.44% |
Cash from operations | -940.00K | 37.08% |
Cash from investing | 9.00K | — |
Cash from financing | 2.70M | 269,800.00% |
Net change in cash | 1.77M | 216.24% |
Free cash flow | -351.38K | 70.28% |
About
Founded
1995
Headquarters
Website
Employees
7
